Steen Knudsen
Chief Scientific Officer Pre-Clin, Co-Founder and
Oncology
Oncology Venture
Sweden
Biography
Knudsen, born 1961, is a member of the Board of Directors of Oncology Venture Sweden AB (publ) since 2015, and as of May 2015, will also be a member of the Board of Directors of the wholly owned subsidiary Oncology Venture ApS. Knudsen is also one of the founders of Oncology Venture ApS, and also co-founder of Medical Prognosis Institute A/S. Knudsen is a Professor of Systems Biology with extensive expertise in mathematics, bioinformatics, biotechnology, and systems biology.
Research Interest
Furthermore, Knudsen is the inventor of Drug Response Prediction which Oncology Venture has a license from Medical Prognosis Institute A/S. Steen Knudsen represents the majority shareholder, Medical Prognosis Institute A/S. Owns no shares, however holds 5,000 warrants in the Company.
